By: Benzinga
Bristol-Myers, Pfizer Announce Positive Phase 3 Trial Results for ELIQUIS
Bristol-Myers Squibb Company (NYSE: BMY ) and Pfizer Inc. (NYSE: PFE ) today announced the results of the Phase 3 AMPLIFY-EXT trial, which evaluated treatment with ELIQUIS®
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here